Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for gestational diabetes
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
Active Compared With Expectant Delivery Management in Women With GestationalDiabetes: A Systematic Review 19104376 2008 12 31 2009 02 24 2014 12 22 0029-7844 113 1 2009 Jan Obstetrics and gynecology Obstet Gynecol Active compared with expectant delivery management in women with gestationaldiabetes: a systematic review. 206-17 10.1097/AOG.0b013e31818db36f We conducted a systematic review to estimate benefits and harms of the choice of timing of induction or elective cesarean delivery based (...) on estimated fetal weight or gestational age in women with gestationaldiabetesmellitus (GDM). An electronic literature search was performed using MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature, and The Cochrane Central Register of Controlled Trials from inception to January 2007. Two investigators independently reviewed titles and abstracts, assessed article quality, and abstracted data. Maternal outcomes included cesarean delivery and operative vaginal delivery. Neonatal
A multicenter, randomized trial of treatment for mild gestationaldiabetes. 19797280 2009 10 02 2009 10 06 2016 12 03 1533-4406 361 14 2009 Oct 01 The New England journal of medicine N. Engl. J. Med. A multicenter, randomized trial of treatment for mild gestationaldiabetes. 1339-48 10.1056/NEJMoa0902430 It is uncertain whether treatment of mild gestationaldiabetesmellitus improves pregnancy outcomes. Women who were in the 24th to 31st week of gestation and who met the criteria for mild (...) gestationaldiabetesmellitus (i.e., an abnormal result on an oral glucose-tolerance test but a fasting glucose level below 95 mg per deciliter [5.3 mmol per liter]) were randomly assigned to usual prenatal care (control group) or dietary intervention, self-monitoring of blood glucose, and insulin therapy, if necessary (treatment group). The primary outcome was a composite of stillbirth or perinatal death and neonatal complications, including hyperbilirubinemia, hypoglycemia, hyperinsulinemia, and birth
A blood pressure before and during early pregnancy is associated with an increased risk of gestationaldiabetesmellitus 18809624 2008 11 26 2009 04 24 2016 10 19 1935-5548 31 12 2008 Dec Diabetes care Diabetes Care High blood pressure before and during early pregnancy is associated with an increased risk of gestationaldiabetesmellitus. 2362-7 10.2337/dc08-1193 While women with prior gestationaldiabetesmellitus (GDM) are more likely to display features of the metabolic syndrome, including (...) hypertension, in the years after delivery, it is unclear whether these components are also present before pregnancy. We examined the relationship between blood pressure (BP) measured before and during early pregnancy (<20 weeks) and the risk of GDM in a nested case-control study. Case (n = 381) and control (n = 942) subjects were selected from a cohort of women delivering between 1996 and 1998 and screened for GDM between 24 and 28 weeks' gestation. GDM was defined by the National Diabetes Data Group
Gestational Weight Gain and GestationalDiabetesMellitus: Perinatal Outcomes 18978100 2008 11 03 2008 12 24 2009 10 26 0029-7844 112 5 2008 Nov Obstetrics and gynecology Obstet Gynecol Gestational weight gain and gestationaldiabetesmellitus: perinatal outcomes. 1015-22 10.1097/AOG.0b013e31818b5dd9 To examine the association between gestational weight gain and perinatal outcome in women with gestationaldiabetesmellitus (GDM). This is a retrospective cohort study of women with nonanomalous (...) singleton pregnancies with GDM enrolled in the Sweet Success California Diabetes and Pregnancy Program between 2001 and 2004. Gestational weight gain, calculated from prepregnancy weight and weight at last prenatal Sweet Success visit, was subgrouped into below, within, and above the Institute of Medicine (IOM) weight-gain guidelines. Perinatal outcomes were examined using chi2 test and multivariable regression analysis with 15-35-lb weight gain as the reference group. There were 31,074 women meeting
Standards of medical care in diabetes. III. Detection and diagnosis of gestationaldiabetesmellitus (GDM). Standards of medical care in diabetes. III. Detection and diagnosis of gestationaldiabetesmellitus (GDM). | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:006279 This guideline summary has been replaced by an updated version. Please update your bookmarks. View the updated summary: NGC:007721 View
Screening for GestationalDiabetesMellitus Screening: GestationalDiabetesMellitus U.S. Preventive Services Task Force Screening for GestationalDiabetesMellitus Release Date: 2003 / Summary of Recommendations The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend for or against routine screening for gestationaldiabetes. Rating: . Rationale : The USPSTF found fair to good evidence that screening combined with diet and insulin therapy can (...) reduce the rate of fetal macrosomia in women with gestationaldiabetesmellitus (GDM). The USPSTF found insufficient evidence, however, that screening for GDM substantially reduces important adverse health outcomes for mothers or their infants (for example, cesarean delivery, birth injury, or neonatal morbidity or mortality). Screening produces frequent false-positive results, and the diagnosis of GDM may be associated with other harms, such as negatively affecting a woman's perception of her health
Screening for gestationaldiabetesmellitus: a systematic review for the U.S. Preventive Services Task Force. Screening for gestationaldiabete... preview & related info | Mendeley E-mail address Password ( ) Remember me …or sign in with Search Main Navigation › Short URL Annals of Internal Medicine ( 2008 ) Volume: 148 , Issue: 10 , Publisher: Agency for Healthcare Research and Quality (AHRQ) , Pages: 766-775 PubMed: Available from or Find this paper at: Abstract BACKGROUND: In 2003, the U.S (...) . Preventive Services Task Force concluded that evidence was insufficient to advise for or against routinely screening all pregnant women for gestationaldiabetesmellitus. PURPOSE: To review evidence about the benefits and harms of screening for gestationaldiabetes. DATA SOURCES: Databases (MEDLINE, Database of Abstracts of Reviews of Effects, Health Technology Assessment Database, National Institute for Health and Clinical Effectiveness, and Cochrane Library) were searched for reports published from
Screening for gestationaldiabetesmellitus: U.S. Preventive Services Task Force recommendation statement. DESCRIPTION: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestationaldiabetes. METHODS: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical (...) and psychological harms) of screening for gestationaldiabetesidentified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. RECOMMENDATION: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestationaldiabetesmellitus, either before or after 24 weeks
Dietary advice in pregnancy for preventing gestationaldiabetesmellitus. BACKGROUND: Gestationaldiabetesmellitus (GDM) is a form of diabetes that occurs during pregnancy which can result in significant adverse outcomes for mother and child both in the short and long term. The potential for adverse outcomes, in addition to the increasing prevalence of gestationaldiabetesworldwide, demonstrates the need to assess strategies, such as dietary advice, that might prevent gestationaldiabetes (...) . OBJECTIVES: To assess the effects of dietary advice in preventing gestationaldiabetesmellitus. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (January 2008) and reference lists of retrieved articles. SELECTION CRITERIA: Quasi-randomised and randomised studies of dietary intervention for preventing glucose intolerance in pregnancy. DATA COLLECTION AND ANALYSIS: Two review authors independently conducted data extraction and quality assessment. We resolved
High prevalence of type 2 diabetesand pre-diabetes in adult offspring of women with gestationaldiabetesmellitus or type 1 diabetes: the role of intrauterine hyperglycemia 18000174 2008 01 29 2008 03 07 2008 01 29 1935-5548 31 2 2008 Feb Diabetes care Diabetes Care High prevalence of type 2 diabetesand pre-diabetes in adult offspring of women with gestationaldiabetesmellitus or type 1 diabetes: the role of intrauterine hyperglycemia. 340-6 The role of intrauterine hyperglycemia and future (...) risk of type 2 diabetesin human offspring is debated. We studied glucose tolerance in adult offspring of women with either gestationaldiabetesmellitus (GDM) or type 1 diabetes, taking the impact of both intrauterine hyperglycemia and genetic predisposition to type 2 diabetesinto account. The glucose tolerance status following a 2-h 75-g oral glucose tolerance test (OGTT) was evaluated in 597 subjects, primarily Caucasians, aged 18-27 years. They were subdivided into four groups according
Screening for gestationaldiabetesmellitus Screening for gestationaldiabetesmellitus Screening for gestationaldiabetesmellitus Hillier T, Vesco K, Whitlock E, Pettitt D, Pedula K, Beil T Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hillier T, Vesco K, Whitlock E, Pettitt D, Pedula K, Beil T. Screening for gestationaldiabetes (...) mellitus. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Synthesis No 60. 2008 Authors' objectives This review identifies and evaluates new evidence since the prior review on the risks and benefits of GDM screening at 24 weeks or later; it also newly reviews all of the available evidence pertaining to GDM screening prior to 24 weeks. Authors' conclusions We found limited evidence to evaluate early screening for GDM prior to 24 weeks gestation, the purpose of which would
Screening for gestationaldiabetesScreening for gestationaldiabetesScreening for gestationaldiabetesLiufu V, Mundy L, Hiller JE Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Liufu V, Mundy L, Hiller JE. Screening for gestationaldiabetes. Adelaide: Adelaide Health Technology Assessment (AHTA). Prioritising Summary. Volume 21. 2008 (...) Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Diabetes, Gestationals; Mass Screening; Pregnancy Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence Adelaide Health Technology Assessment, University of Adelaide, Discipline of Public Health, School of Population Health and Clinical Practice, Mail Drop DX650545, SA 5005 Adelaide Australia Email: firstname.lastname@example.org
Therapeutic management, delivery, and postpartum risk assessment and screening in gestationaldiabetesTherapeutic management, delivery, and postpartum risk assessment and screening in gestationaldiabetesTherapeutic management, delivery, and postpartum risk assessment and screening in gestationaldiabetesNicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K, Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB Citation Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K (...) , Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB. Therapeutic management, delivery, and postpartum risk assessment and screening in gestationaldiabetes. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 162. 2008 Authors' objectives
We focused on four questions: (1) What are the risks and benefits of an oral diabetes agent (i.e., glyburide), as compared to all types of insulin, for gestationaldiabetes? (2) What
The role of exercise in preventing and treating gestationaldiabetes: a comprehensive review and recommendations for future research The role of exercise in preventing and treating gestationaldiabetes: a comprehensive review and recommendations for future research The role of exercise in preventing and treating gestationaldiabetes: a comprehensive review and recommendations for future research DiNallo J M, Downs D S CRD summary The authors concluded that exercise may have positive (...) and protective effects for the treatment and prevention of GDM (gestationaldiabetesmellitus). In view of poor reporting in the review, the small number of controlled studies, failure to assess or address heterogeneity between the studies and failure to systematically assess study quality, it is impossible to determine the reliability of the conclusions. Authors' objectives To assess the effects of exercise for treating, preventing or delaying GDM. Searching PsycLit, MEDLINE, Dissertation Abstracts Online
Therapeutic management, delivery, and postpartum risk assessment and screening in gestationaldiabetesTherapeutic management, delivery, and postpartum risk assessment and screening in gestationaldiabetesTherapeutic management, delivery, and postpartum risk assessment and screening in gestationaldiabetesNicholson W K, Wilson L M, Witkop C T, Baptiste-Roberts K, Bennett W L, Bolen S, Barone B B, Golden S H, Gary T L, Neale D M, Bass E B CRD summary This review assessed treatment, delivery (...) options and subsequent testing for type-2 diabetesfor women with gestationaldiabetes. The authors concluded that there was insufficient evidence to recommend insulin alternatives or to formulate delivery guidelines and the 75-gm OGTT test should be retained for post-partum testing. This was a well-conducted review. The conclusions reflected the limited evidence accurately and are likely to be reliable. Authors' objectives Identified objectives were: to determine the efficacy and safety of oral
Screening for gestationaldiabetesmellitus Screening for gestationaldiabetesmellitus Screening for gestationaldiabetesmellitus Hillier T A, Vesco K K, Whitlock E P, Pettitt D J, Pedula K L, Beil T L CRD summary The authors of this well-conducted review concluded that the limited evidence about early (<24 weeks) gestationaldiabetesmellitus (GDM) indicates a need for more research. The conclusion, which was based on one recent good-quality study in which screening identified women (...) with mild GDM after 24 weeks' gestation and improved maternal and neonatal outcomes, is likely to be reliable. Authors' objectives To evaluate the benefits and harms of screening for gestationaldiabetesmellitus (GDM). Searching MEDLINE, the Cochrane CENTRAL Register, the Cochrane Database of Systematic Reviews, DARE, HTA and the National Institute for Health and Clinical Excellence were searched from 2000 to September 2006l the search terms were reported. In addition, the reference lists from